Suppr超能文献

利用神经肽Y1选择性拮抗剂BIBP 3226区分大鼠尾动脉中的神经肽Y和肽YY。

Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.

作者信息

Gicquiaux H, Tschöpl M, Doods H N, Bucher B

机构信息

Laboratoire de Pharmacologie et Physiopathologie Cellulaires, C.N.R.S. URA 600, Université Louis Pasteur Strasbourg, Illkirch, France.

出版信息

Br J Pharmacol. 1996 Dec;119(7):1313-8. doi: 10.1111/j.1476-5381.1996.tb16040.x.

Abstract
  1. The ability of the novel, nonpeptide, neuropeptide Y (NPY) Y1-selective antagonist, BIBP 3226 ¿(R)-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-D-arginine amide¿, to antagonize the increase in perfusion pressure induced by NPY and peptide Y (PYY) was tested in the perfused rat tail artery, a postjunctional Y1-receptor bioassay, precontracted by 1 microM phenylephrine. 2. NPY and PYY produced a concentration-dependent enhancement of the vasoconstrictor response evoked by 1 microM phenylephrine. Although NPY and PYY are roughly equipotent, the maximal contractile response elicited by PYY was about twice that elicited by NPY. 3. Increasing concentrations of BIBP 3226 caused a parallel and rightward shift in the NPY concentration-response curve without depressing the maximal response. The contractile effect of NPY was potently inhibited in a competitive manner. The pA2 value for BIBP 3226 was 7.01 +/- 0.08, a value equivalent to that observed in the rabbit saphenous vein. Although increasing concentrations of BIBP 3226 shifted the concentration-response curve of PYY to the right without any significant decrease in the maximal vasoconstrictor response, the antagonism appeared non-competitive as the slope of the Schild plot was significantly different from unity (0.58 +/- 0.04). 4. In conclusion, these data confirm that BIBP 3226 is a potent and selective nonpeptide Y1 receptor antagonist. Moreover, they show that complex interactions occur between BIBP 3226 and postjunctional receptors activated by PYY. We postulate that BIBP 3226 might discriminate between the effects of NPY and PYY at the postjunctional level in the rat tail artery. It may be that distinct receptors for NPY and PYY exist; these may or may not allosterically interact with each other. Another working hypothesis would be that there is a single receptor complex with allosterically interacting binding sites for the two peptides.
摘要
  1. 在灌注大鼠尾动脉(一种节后Y1受体生物测定法)中,测试了新型非肽类神经肽Y(NPY)Y1选择性拮抗剂BIBP 3226((R)-N2-(二苯基乙酰基)-N-[(4-羟基苯基)甲基]-D-精氨酸酰胺)拮抗由NPY和肽YY(PYY)诱导的灌注压力升高的能力,该动脉由1微摩尔去氧肾上腺素预收缩。2. NPY和PYY使由1微摩尔去氧肾上腺素引起的血管收缩反应呈浓度依赖性增强。虽然NPY和PYY大致等效,但PYY引起的最大收缩反应约为NPY引起的两倍。3. 增加BIBP 3226的浓度会使NPY浓度-反应曲线平行右移,而不降低最大反应。NPY的收缩作用以竞争性方式被有效抑制。BIBP 3226的pA2值为7.01±0.08,这一数值与在兔隐静脉中观察到的数值相当。虽然增加BIBP 3226的浓度会使PYY的浓度-反应曲线右移,且最大血管收缩反应无明显降低,但由于施尔德图的斜率显著不同于1(0.58±0.04),这种拮抗作用似乎是非竞争性的。4. 总之,这些数据证实BIBP 3226是一种强效且选择性的非肽Y1受体拮抗剂。此外,它们表明BIBP 3226与由PYY激活的节后受体之间发生复杂的相互作用。我们推测BIBP 3226可能在大鼠尾动脉的节后水平区分NPY和PYY的作用。可能存在NPY和PYY的不同受体;它们可能会或可能不会彼此变构相互作用。另一个可行的假设是存在一个单一的受体复合物,其具有两个肽的变构相互作用结合位点。

相似文献

本文引用的文献

1
Some quantitative uses of drug antagonists.药物拮抗剂的一些定量应用。
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验